Pharm
Intranasal Dihydroergotamine
search
Intranasal Dihydroergotamine
, Migranal, Atzumi Nasal Powder Inhaler
See Also
Dihydroergotamine
Migraine Abortive Management
Indications
Migraine Abortive Management
Largely replaced by
Triptan
s
Contraindications
See
Dihydroergotamine
Mechanism
See
Dihydroergotamine
Medications
Intranasal Dihydroergotamine
Migranal Nasal Spray: 0.5 mg per spray
Atzumi Nasal Powder Inhaler 5.2 mg/device
Precautions
Give first dose in health care facility in those with
Cardiovascular Risk Factor
s
Dosing
Adults
Migranal
Prepare sprayer by inserting ampule and prime pump (4 squeezes before first use)
Use one spray each nostril
May repeat x1 after 15 minutes (Total dose = 2mg)
Maximum
Day: 6 sprays (3 mg/day)
Weekly: Twice per week or 8 sprays/week (4 mg/week)
Atzumi Nasal Powder Inhaler
Setup device (no priming needed)
Spray one device into 1 nostril
May repeat 1 spray into the same single nostril after 1 hour
Maximum
Day: 2 sprays (10.4 mg/day)
Weekly: 4 dose maximum
Monthly: 12 dose maximum
Adverse Effects
Rhinitis
Nausea
Taste perversion
Safety
Avoid in Pregnancy (Pregnancy Category X)
Avoid in
Lactation
Efficacy
Significant
Migraine
response in 30 minutes
Migranal: 70%
Placebo
: 28%
Reference
Gallagher (1996) Arch Neurol 53:1285-91 [PubMed]
Advantages
Lasts longer than intranasal
Imitrex
Rebound Headache
less common than
Imitrex
Rebound Headache
Incidence
: 15% within 24 hours
Less expensive than Intranasal
Imitrex
($16/dose)
Disadvantages
Does not work as fast as intranasal
Imitrex
More complicated to use than intranasal
Imitrex
Resources
Intranasal Dihydroergotamine (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=977de209-c53a-4cb4-9f3f-1e850600a9dc
Type your search phrase here